Woldu, S. L. Et Al. 2018. Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study. CLINICAL GENITOURINARY CANCER , vol.16, no.6 .

Woldu, S. L., Matulay, J. T., Clinton, T. N., Singla, N., Freifeld, Y., Sanli, O., ... Krabbe, L.(2018). Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study. CLINICAL GENITOURINARY CANCER , vol.16, no.6.

Woldu, Solomon Et Al. "Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study," CLINICAL GENITOURINARY CANCER , vol.16, no.6, 2018

Woldu, Solomon L. Et Al. "Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study." CLINICAL GENITOURINARY CANCER , vol.16, no.6, 2018

Woldu, S. L. Et Al. (2018) . "Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study." CLINICAL GENITOURINARY CANCER , vol.16, no.6.

@article{article, author={Solomon L. Woldu Et Al. }, title={Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study}, journal={CLINICAL GENITOURINARY CANCER}, year=2018}